NASDAQ: VALN

Valneva Se Stock Forecast, Predictions & Price Target

The consensus among 2 Wall Street analysts covering (NASDAQ: VALN) stock is to Strong Buy VALN stock.

Out of 2 analysts, 1 (50%) are recommending VALN as a Strong Buy, 1 (50%) are recommending VALN as a Buy, 0 (0%) are recommending VALN as a Hold, 0 (0%) are recommending VALN as a Sell, and 0 (0%) are recommending VALN as a Strong Sell.

If you're new to stock investing, here's how to buy Valneva Se stock.

(NASDAQ: VALN) Valneva Se's forecast annual revenue growth rate of 30.41% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Valneva Se's revenue in 2024 is $167,079,347.On average, 3 Wall Street analysts forecast VALN's revenue for 2024 to be $32,033,973,418, with the lowest VALN revenue forecast at $27,372,637,581, and the highest VALN revenue forecast at $41,272,186,510. On average, 3 Wall Street analysts forecast VALN's revenue for 2025 to be $35,884,617,994, with the lowest VALN revenue forecast at $34,200,169,360, and the highest VALN revenue forecast at $37,156,219,742.

In 2026, VALN is forecast to generate $53,827,065,904 in revenue, with the lowest revenue forecast at $47,250,965,101 and the highest revenue forecast at $59,835,016,045.

According to 2 Wall Street analysts that have issued a 1 year VALN price target, the average VALN price target is $21.50, with the highest VALN stock price forecast at $26.00 and the lowest VALN stock price forecast at $17.00.

On average, Wall Street analysts predict that Valneva Se's share price could reach $21.50 by Mar 22, 2025. The average Valneva Se stock price prediction forecasts a potential upside of 177.42% from the current VALN share price of $7.75.

(NASDAQ: VALN) forecast ROE is N/A, which is considered weak.